Cresco Labs (CRLBF) Change in Accured Expenses (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Change in Accured Expenses came in at -$7.6 million in Q1 2026, down 154.76% YoY from $13.9 million in Q1 2025, and down 171.8% on a QoQ basis from $10.6 million in Q4 2025.
Cresco Labs (CRLBF) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Change in Accured Expenses data on file, last reported at -$7.6 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 154.76% year-over-year to -$7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.9 million (down 430.3% YoY) and the FY2025 annual result came in at $8.6 million, up 150.94% from the prior year.
- Change in Accured Expenses retreated to -$7.6 million in Q1 2026, from $10.6 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $20.1 million in Q1 2023 to a low of -$20.5 million in Q4 2024.
- A 5-year average of $1.7 million and a median of $934500.0 in 2022 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 38751.28% in 2022, down 5712.78% in 2022.
- Tracing CRLBF's Change in Accured Expenses over 5 years: stood at $15.1 million in 2022, then slumped by 176.34% to -$11.5 million in 2023, then tumbled by 77.9% to -$20.5 million in 2024, then jumped by 151.87% to $10.6 million in 2025, then slumped by 171.8% to -$7.6 million in 2026.
- The last three Change in Accured Expenses figures came in at -$7.6 million (Q1 2026), $10.6 million (Q4 2025), and -$5.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | -356,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.62 Mn |
| Mar 31, 2026 | -7.62 Mn |
| Dec 31, 2025 | 10.62 Mn |
| Dec 31, 2025 | 10.62 Mn |
| Sep 30, 2025 | -5.31 Mn |
| Sep 30, 2025 | -5.31 Mn |
| Jun 30, 2025 | -10.62 Mn |
| Jun 30, 2025 | -10.62 Mn |
| Mar 31, 2025 | 13.92 Mn |
| Mar 31, 2025 | 13.92 Mn |
| Dec 31, 2024 | -20.47 Mn |
| Dec 31, 2024 | -20.47 Mn |
| Sep 30, 2024 | 15.67 Mn |
| Sep 30, 2024 | 15.67 Mn |
| Jun 30, 2024 | -5.20 Mn |
| Jun 30, 2024 | -5.20 Mn |
| Mar 31, 2024 | -6.91 Mn |
| Mar 31, 2024 | -6.91 Mn |
| Dec 31, 2023 | -11.51 Mn |
| Dec 31, 2023 | -11.51 Mn |